Elizabeth S Aby

Elizabeth S Aby is an Assistant Professor in the Department of Medicine at the University of Texas, specializing in Gastroenterology and Hepatology. Her research focuses on hepatocellular carcinoma, liver transplantation, nonalcoholic fatty liver disease, and the impact of social determinants on liver disease outcomes. She leads the National Liver Cancer Screening Trial (TRACER), a NIH-funded project addressing liver cancer screening strategies.

Her work integrates clinical practice with public health initiatives, emphasizing equity in healthcare access and outcomes. Key projects include studies on opioid use in transplant recipients, financial toxicity in liver transplantation, and cervical cancer screening practices among transplant patients. She has published extensively on liver disease management, including articles on alcohol-related liver disease, metabolic dysfunction-associated steatotic liver disease, and the effects of SGLT2 inhibitors.

Aby collaborates nationally and internationally, contributing to guidelines and policy development in transplant hepatology. Her research also addresses barriers to transplant fellowship training, leadership development for young faculty, and the role of social media in medical education.